Waycen’s artificial intelligence solution to help gastric cancer diagnosis has been designated as an innovative medical device.The Ministry of Food and Drug Safety (MFDS) said Wednesday that it has designated Waycen’s gastric cancer image detection and diagnosis aid software, WAYMED Endo ST CS, as t
Novomics, a cancer diagnostics company, has patented a genetic prognostic technology for rectal cancer in Korea, the company said on Friday. The technology can screen high-risk rectal cancer patients who are more likely to have recurrences based on the molecular subtypes of their cancer.In particula
Korea’s DTx market launched in earnest with the domestic approval of two cognitive-based treatment (CBT) digital therapeutics (DTx) for treating insomnia -- Aimmed’s Somzz and Welt’s Pillowbot in February and April, respectively.According to a report released on Tuesday by the Korea Innovative Medic
CGBio, a Korean regenerative biopharmaceutical company, said Tuesday that Novomax Fusion, aitsnext-generation osteo-active bioglass ceramic cage, has received approval from Japan’s Pharmaceutical and Medical Devices Agency (PMDA).According to CGBio, Novomax Fusion is a synthetic glass-ceramic spacer
Seegene's minority shareholders, angered by the continued fall of the company's stock price, are taking collective action, calling for the resignation of the founder and CEO Chun Jong-yoon.Seegene, the maker of Covid-19 PCR test devices, benefited greatly from the Covid-19 pandemic. While the compan
Theragen Bio and Korea University Ansan Hospital (KUAH) said they would team up to utilize precision genomic data.In a memorandum of understanding (MOU) signed between the two organizations last Thursday, Theragen Bio will leverage its over 10 years of expertise and technology to generate and provid
With the increasing incidence of lung cancer in Korea, special attention is being focused on methods to enable early diagnosis of lung cancer to enable better prognosis for patients.The increase in air pollution, smoking rates, and poor industrial working conditions have been cited as the main cause
Hong Kong-based investment firm Well Alike, one of Lunit's early investors, has sold some of its shares in the market.The medical AI company said the sale was in line with Well Alike's investment strategy, having nothing to do with the company’s internal circumstances.On Tuesday, Well Alike sold 588
Lunit said on Wednesday that it will collaborate with Seha Virtual Hospital (SVH) to supply its AI solutions for chest and mammography to drive healthcare transformation across Saudi Arabia in alignment with the Saudi Vision 2030 strategy project.Lunit has already delivered Lunit INSIGHT CXR, its AI
Qiagen Korea said on Monday that its companion diagnostic (CDx) -- screening PIK3CA gene in patients suitable for prescribing Novartis’ breast cancer treatment Piqray (ingredient: alpelisib) -- started receiving reibmursement from July 1.The insurance coverage will benefit postmenopausal patients wi
As Korean big tech companies, such as telecom carriers and platforms, prepare to enter the digital medical device market, the Ministry of Food and Drug Safety (MFDS) has promised to improve regulations by collecting industry opinions. The attention now is on how the digital medical device market, do
Huons Meditech said on Tuesday that it signed a memorandum of understanding with LVIS, a Silicon Valley-based digital brain disease diagnosis company, to commercialize its AI platform, NeuroMatch.The software aims to innovate how neurological diseases are examined.NeuroMatch, developed by LVIS, is a
NGeneBio said on Monday a study found that gene-specific machine-learning models are more efficient at predicting the pathogenicity of rare genetic variants than disease-specific machine-learning models.The research paper is about interpreting the pathogenicity of BRCA1/2 genetic variants, in rare d
A GE Healthcare Korea employee was reportedly killed during a routine inspection of computed tomography (CT) device at a hospital in Seongnam, Gyeonggi Province, on Tuesday.According to reports from the medical community on Wednesday, the CT table fell down on the employee while he was inspecting a
Ybrain said on Wednesday that it was selected by the Ministry of Health and Welfare (MOHW) to conduct two electronic drug-related studies under the 2023 Electronic Drug Technology Development project to expand indications to treat perinatal depression.Ybrain will conduct one study for “demonstration
Kim Hyun-joon, founder and former CEO of VUNO, partnered with Professor Park Sang-joon of the Department of Ophthalmology at Seoul National University Bundang Hospital to launch CLOP, an AI-based eye disease management startup.The startup has also received seed investment.CLOP said it recently drew
Boston Scientific Korea said it has launched Wolverine Cutting Balloon Dilatation Device, a catheter for use in percutaneous coronary intervention (PCI).PCI is a minimally invasive treatment that uses balloon catheters or stents to widen narrowed coronary arteries to improve blood flow to the heart.
Lunit said on Monday FujiFilm's AI solution for chest X-ray analysis, CXR-AID, which uses Lunit INSIGHT CXR software, has obtained health insurance reimbursement in Japan.As of 11:02 a.m. Monday, Lunit's stocks on Kosdaq jumped by approximately 25 percent.The reimbursement is provided under the "Ima
Coreline Soft said it has submitted a filing with Shinhan 7th Special Purpose Acquisition Company to the Financial Services Commission and plans to start trading on the tech-heavy Kosdaq market in September. The merger will be an absorption merger, in which Coreline will absorb Shinhan 7th Special P
Kakao Healthcare said it has signed a global collaboration agreement with Dexcom to provide CGM (continuous glucose monitoring) based blood glucose management services in Korea first, and then in other countries.In April, the two signed a memorandum of understanding (MOU) in Boston, U.S., to pursue